Will NeoGenomics (NEO) Leverage Its RaDaR ST Validation to Strengthen Competitive Positioning?
Simply Wall St 02/11 07:46
RBC Capital Reiterates Outperform on R1 RCM, Maintains $19 Price Target
R1 RCM Inc Delist
R1 RCM Inc RCM | 0.00 |
RBC Capital analyst Sean Dodge reiterates R1 RCM (NASDAQ:
RCM) with a Outperform and maintains $19 price target.
Recommend
Blackstone (BX): Exploring the Valuation Behind Recent Share Price Declines
Simply Wall St 02/11 07:44Gentherm (THRM) Valuation in Focus After Raised Full-Year Earnings Guidance and Q3 Results
Simply Wall St 02/11 09:27eXp World Holdings (EXPI): Assessing Valuation Potential After Recent Modest Share Price Uptick
Simply Wall St 02/11 10:31Silgan Holdings (SLGN): Assessing Valuation After Lowered Profit Outlook and Post-Earnings Selloff
Simply Wall St 02/11 10:38What United Rentals (URI)'s Raised Guidance and Margin Pressures Mean for Shareholders
Simply Wall St 02/11 10:35Stem (STEM): Assessing Valuation Following Q3 Earnings Beat and Upgraded 2025 Forecast
Simply Wall St 02/11 11:29A Look at InterDigital’s (IDCC) Valuation Following Strong Q3 Results and Upbeat Outlook
Simply Wall St 02/11 12:43
